HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The significance of α-synuclein, amyloid-β and tau pathologies in Parkinson's disease progression and related dementia.

AbstractBACKGROUND:
Dementia is one of the milestones of advanced Parkinson's disease (PD), with its neuropathological substrate still being a matter of debate, particularly regarding its potential mechanistic implications.
OBJECTIVE:
The aim of this study was to review the relative importance of Lewy-related α-synuclein and Alzheimer's tau and amyloid-β (Aβ) pathologies in disease progression and dementia in PD.
METHODS:
We reviewed studies conducted at the Queen Square Brain Bank, Institute of Neurology, University College London, using large PD cohorts.
RESULTS:
Cortical Lewy- and Alzheimer-type pathologies are associated with milestones of poorer prognosis and with non-tremor predominance, which have been, in turn, linked to dementia. The combination of these pathologies is the most robust neuropathological substrate of PD-related dementia, with cortical Aβ burden determining a faster progression to dementia.
CONCLUSION:
The shared relevance of these pathologies in PD progression and dementia is in line with experimental data suggesting synergism between α-synuclein, tau and Aβ and with studies testing these proteins as disease biomarkers, hence favouring the eventual testing of therapeutic strategies targeting these proteins in PD.
AuthorsYaroslau Compta, Laura Parkkinen, Peter Kempster, Mariana Selikhova, Tammaryn Lashley, Janice L Holton, Andrew J Lees, Tamas Revesz
JournalNeuro-degenerative diseases (Neurodegener Dis) Vol. 13 Issue 2-3 Pg. 154-6 ( 2014) ISSN: 1660-2862 [Electronic] Switzerland
PMID24028925 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amyloid beta-Peptides
  • alpha-Synuclein
  • tau Proteins
Topics
  • Amyloid beta-Peptides (metabolism)
  • Brain (metabolism, pathology)
  • Dementia (etiology, metabolism, pathology)
  • Disease Progression
  • Humans
  • Parkinson Disease (complications, metabolism, pathology)
  • Retrospective Studies
  • alpha-Synuclein (metabolism)
  • tau Proteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: